Skip to main content
uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
5.84
+0.14 (2.46%)
Nov 21, 2024, 1:49 PM EST - Market open

uniQure Revenue

uniQure had revenue of $2.29M in the quarter ending September 30, 2024, with 62.54% growth. This brings the company's revenue in the last twelve months to $28.59M, down -74.45% year-over-year. In the year 2023, uniQure had annual revenue of $15.84M, down -85.12%.

Revenue (ttm)
$28.59M
Revenue Growth
-74.45%
P/S Ratio
9.65
Revenue / Employee
$59,556
Employees
480
Market Cap
283.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.84M-90.64M-85.12%
Dec 31, 2022106.48M-417.52M-79.68%
Dec 31, 2021524.00M486.49M1,296.82%
Dec 31, 202037.51M30.23M415.23%
Dec 31, 20197.28M-4.00M-35.48%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OraSure Technologies 224.26M
Vanda Pharmaceuticals 190.86M
Voyager Therapeutics 163.78M
Sage Therapeutics 106.40M
C4 Therapeutics 33.67M
ClearPoint Neuro 30.43M
Atai Life Sciences 331.00K
Revenue Rankings

QURE News

More News